Taro Pharmaceutical
TARO
#4721
Rank
NZ$2.75 B
Marketcap
$73.32
Share price
0.00%
Change (1 day)
8.59%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): $0.99

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.04. In 2021 the company made an earnings per share (EPS) of $0.06825 an increase over its 2020 EPS that were of -$13.50.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.99
2021$0.06825-100.51%
2020-$13.50-222.45%
2019$11.02-18.02%
2018$13.4453.01%
2017$8.79-55.95%
2016$19.95-13.41%
2015$23.0336.92%
2014$16.8237.71%
2013$12.2221.15%
2012$10.0844.15%
2011$7.00175.17%
2010$2.54-48.8%
2009$4.97
2005$0.05119-91.89%
2004$0.63-82.55%
2003$3.6235.9%
2002$2.6639.29%
2001$1.91140.86%
2000$0.7969.09%
1999$0.47139.13%
1998$0.2064.29%
1997$0.12-36.36%
1996$0.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.17 204.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.11 198.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.03 2,209.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.41-427.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$5.97 473.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.38 513.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland